• Tel. 900 101 549
  • +34 93 546 01 35
  • Facebook IOR
  • Twitter IOR
  • LinkedIn IOR
  • Hospital Universitari Dexeus
  • Centro Médico Teknon
  • Hospital Universitari General de Cataluña
  • Hospital Universitari Sagrat Cor

SCIENTIFIC PUBLICATIONS

Our medical oncologists and laboratory investigators are at the forefront of investigations into the causes of cancer and the search for novel treatments.

We have published the results of our investigations, often in collaboration with some of the most prestigious international institutions, in renowned medical journals such as the New England Journal of Medicine, Clinical Cancer Research, and many others.

CONSULT OUR SCIENTIFIC PUBLICATIONS

01/04/2015

ROS1 rearrangements in lung adenocarcinoma: prognostic impact, therapeutic options and genetic variability

AUTHORS Scheffler M, Schultheis A, Teixido C, Michels S, Morales-Espinosa D, Viteri S, Hartmann W, Merkelbach-Bruse S, Fischer R, Schildhaus HU, Fassunke J, Sebastian M, Serke M, Kaminsky B, Randerath W, Gerigk U, Ko YD, Krüger S, Schnell R, Rothe A, Kropf-Sanchen C, Heukamp L, Rosell R, Büttner R, Wolf J.

PUBLICATION Oncotarget. 2015 Apr 30;6(12):10577-85.

READ ARTICLE

01/04/2015

Subtype Classification of Lung Adenocarcinoma Predicts Benefit From Adjuvant Chemotherapy in Patients Undergoing Complete Resection

AUTHORS Tsao MS, Marguet S, Le Teuff G, Lantuejoul S, Shepherd FA, Seymour L, Kratzke R, Graziano SL, Popper HH, Rosell R, Douillard JY, Le-Chevalier T, Pignon JP, Soria JC, Brambilla EM. J

PUBLICATION Clin Oncol. 2015 Apr 27. [Epub ahead of print]

READ ARTICLE

01/04/2015

AXL mediates resistance to PI3Kα inhibition by activating the EGFR/PKC/mTOR axis in head and neck and esophageal squamous cell carcinomas

AUTHORS Elkabets M, Pazarentzos E, Juric D, Sheng Q, Pelossof RA, Brook S, Benzaken AO, Rodon J, Morse N, Yan JJ, Liu M, Das R, Chen Y, Tam A, Wang H, Liang J, Gurski JM, Kerr DA, Rosell R, Teixidó C, Huang A, Ghossein RA, Rosen N, Bivona TG, Scaltriti M, Baselga J.

PUBLICATION Cancer Cell. 2015 Apr 13;27(4):533-46.

READ ARTICLE

01/03/2015

The Role of Smoking Status on the Progression-Free Survival of Non-Small Cell Lung Cancer Patients Harboring Activating Epidermal Growth Factor Receptor (EGFR) Mutations Receiving First-Line EGFR Tyrosine Kinase Inhibitor Versus Platinum Doublet Chem

AUTHORS Hasegawa Y, Ando M, Maemondo M, Yamamoto S, Isa SI, Saka H, Kubo A, Kawaguchi T, Takada M, Rosell R, Kurata T, Ou SH.

PUBLICATION The Oncologist. 2015 Mar;20(3):307-15.

READ ARTICLE

01/03/2015

Interstitial Lung Disease Arising From Erlotinib Treatment in a Caucasian Patient

AUTHORS Bugés C, Carcereny E, Moran T, Cardona AF, Reguart N, Capdevila L, Cros S, Rosell R.

PUBLICATION Clin Lung Cancer. 2015 Vol. 16, No. 2, e1-3

READ ARTICLE